English
Home > Products > 207226-02-6

China 207226-02-6 Factory

That has a positive and progressive attitude to customer's fascination, our enterprise constantly improves our merchandise high quality to meet the demands of customers and further focuses on safety, reliability, environmental requirements, and innovation of 207226-02-6,CAS NO 207226-02-6,Erlotinib intermediate,Erlotinib advance intermediate,3-Ethynylbenzenamine, Through our hard work, we have always been on the forefront of clean technology product innovation. We are a green partner you can rely on. Contact us today for more information!
207226-02-6, Ought to any of these products be of curiosity to you, make sure you let us know. We will be satisfied to provide you a quotation on receipt of one's in depth specifications. We have now our personalized experienced R&D enginners to meet any of one's requriements, We appear forward to receiving your enquires soon'and hope to have the opportunity to work together with you in the future. Welcome to check out our company.

Related Products

Hot Products

  • 2,4,5,6-Tetraaminopyrimidine sulfate

    2,4,5,6-Tetraaminopyrimidine sulfate

    Product Name:2,4,5,6-Tetraaminopyrimidine sulfate
    Molecular Formula:C4H8N6.H2SO4
    Molecular Weight:238.23
    CAS Registry Number:49647-58-7/5392-28-9
  • 5-Chlorovaleric acid

    5-Chlorovaleric acid

    Product Name:5-Chlorovaleric acid
    Molecular Formula:C5H9ClO2
    Molecular Weight:136.58
    CAS Registry Number:1119-46-6
  • Polaprezinc

    Polaprezinc

    Product Name:Polaprezinc
    Molecular Formula:C9H12N4O3Zn
    Molecular Weight;289.61
    CAS Registry Number;107667-60-7
  • DEPBT

    DEPBT

    Product Name:DEPBT
    Molecular Formula:C11H14N3O5P
    Molecular Weight:299.22
    CAS Registry Number:165534-43-0
  • p-Fluorotoluene

    p-Fluorotoluene

    Product Name:p-Fluorotoluene
    Molecular Formula:C7H7F
    Molecular Weight:110.13
    CAS Registry Number:352-32-9
  • Teicoplanin

    Teicoplanin

    Product Name:Teicoplanin Molecular Formula:C77H77N9O31Cl2.R
    CAS Registry Number;61036-62-2
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Related Search

CAS NO 207226-02-6

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept